ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2492

Functionally Distinct ERAP1 Haplotype Combinations Distinguish Individuals With Ankylosing Spondylitis

Edward James1, Emma Reeves1, Alexandra Colebatch2, Tim Elliott1 and Christopher J. Edwards3, 1Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom, 2Rheumatology, University Hospital Southampton, Southampton, United Kingdom, 3NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and major histocompatibility complex (MHC)

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The association of Ankylosing Spondylitis (AS) with HLA-B27 has been known for many years. Recent genetic linkage studies have identified polymorphisms within the aminopeptidase, ERAP1, associated with the disease. ERAP1 lies on the antigen processing pathway, generating peptide antigens for immune presentation by HLA. We examined the extent of polymorphism of ERAP1 and the haplotype combinations present in affected and control individuals. In addition, we assessed the ability of the identified ERAP1 genotypes to trim peptides for presentation on MHC class I molecules.

Methods:

Individual ERAP1 haplotypes were cloned from patients with AS and control individuals recruited with informed consent and sequenced. ERAP1 trimming function was assessed by observing the ability of Erap1 deficient cells, expressing the identified haplotype molecules, to trim and present peptide for stimulation of an antigen-specific T cell and also to reconstitute surface HLA-B27.

Results:

We found that ERAP1 from both AS cases (n=17) and controls (n=19) are highly polymorphic and comprise nine haplotypes that are predominantly made up of multiple SNPs. ERAP1 haplotype combinations from AS cases were distinct from those found in controls. AS case ERAP1 haplotype combinations trimming capacity was significantly decreased as less than a third of the final epitope was generated from peptide precursors for presentation to T cells compared to controls. In addition, AS case ERAP1 combinations were unable to reconstitute HLA-B27 to normal levels recovering only 50% of that observed with control haplotype combinations.

Conclusion:

These results demonstrate for the first time that ERAP1 from patients with AS is dysfunctional and provides strong evidence that ERAP1 variation predisposes to chronic inflammatory disease via its influence on the antigen processing pathway.


Disclosure:

E. James,
None;

E. Reeves,
None;

A. Colebatch,
None;

T. Elliott,
None;

C. J. Edwards,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functionally-distinct-erap1-haplotype-combinations-distinguish-individuals-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology